Goldfinch News
Goldfinch Health has announced that it has once again successfully completed the rigorous verification process established by the Validation Institute. First validated in 2022, the company’s surgery and recovery navigation platform continues to demonstrate substantial…
Surgery has long been known as a gateway to long-term opioid painkiller use and dependence. Studies show 9% of surgery patients who have never used an opioid become long-term users of opioids after being legally…
North Dakota Health and Human Services (HHS) has announced the recipients of the latest round of Opioid Settlement Fund grants, including funding for Goldfinch Health’s Billion Pill Pledge program. “Opioid settlement funds allow us to…
Tampa Bay Wave unveiled the selection of 16 dynamic companies for the 2025 HealthTech|X Accelerator, including Goldfinch Health. Tampa Bay Wave is a nonprofit technology accelerator named the #1 Accelerator in Florida. “This is our strongest…
Validation Institute has announced the winners of its 8th Annual Health Value Awards celebrating organizations and individuals driving measurable improvements in healthcare value. The awards spotlight top-performing services, products, and programs across more than 20…
Following a comprehensive and data-intensive review process, the City of Mobile and the Helios Alliance selected Goldfinch Health to deliver its Billion Pill Pledge program for the Gulf Coast community. Goldfinch’s proposal was one of…
Recent research published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) demonstrates that Enhanced Recovery After Surgery (ERAS) pathways can dramatically reduce postoperative opioid prescriptions for orthopedic patients. The Results The study…